Skip to main content

Lung Transplantation

  • Chapter
  • First Online:
Diagnosis and Treatment of Pulmonary Hypertension
  • 1175 Accesses

Abstract

Bilateral cadaveric lung transplantation (CLT) is the most common procedure for pulmonary arterial hypertension (PAH) according to the report from International Society for Heart and Lung Transplantation. The 5-year survival after CLT is approximately 50 %, and pulmonary hypertension (PH) is known to be a significant risk factor of early death after lung transplantation.

Because of severe shortage of cadaveric lungs in Japan, living-donor lobar lung transplantation (LDLLT) is often the only realistic option for very sick PAH patients especially for children.

Between 1998 and 2015, lung transplantation has been performed in 464 patients at nine lung transplant centers in Japan. Among these, the author and his colleagues have performed 184 lung transplants including 111 LDLLTs and 73 CLTs. Thirty-five of them (19 %) were diagnosed with PH. Twenty-four patients received LDLLT and 11 patients received CLT. The 5-year survival rate was 81.2 % for PH patients (n = 35) and was 72.2 % for non-PH patients (n = 149).

Lung transplantation is a viable treatment in patients with PAH who failed to respond medical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982;306:557–64.

    Article  CAS  PubMed  Google Scholar 

  2. The Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med. 1986;314:1140–5.

    Article  Google Scholar 

  3. Fremes SE, Patterson GA, Williams WG, et al. Single lung transplantation and closure of patent ductus arteriosus for Eisenmenger’s syndrome. Toronto Lung Transplant Group. J Thorac Cardiovasc Surg. 1990;100:1–5.

    CAS  PubMed  Google Scholar 

  4. Starnes VA, Bowdish ME, Woo MS, et al. A decade of living lobar lung transplantation. Recipient outcomes. J Thorac Cardiovasc Surg. 2004;127:114–22.

    Article  PubMed  Google Scholar 

  5. Date H, Sano Y, Aoe M, Matsubara H, Kusano K, Goto K, Tedoriya T, Shimizu N. Living-donor single lobe lung transplantation for primary pulmonary hypertension in a child. J Thorac Cardiovasc Surg. 2002;123:1211–3.

    Article  PubMed  Google Scholar 

  6. Date H, Nagahiro I, Aoe M, Matsubara H, Kusano K, Goto K, Shimizu N. Living-donor lobar lung transplantation for primary pulmonary hypertension in an adult. J Thorac Cardiovasc Surg. 2001;122:817–8.

    Article  CAS  PubMed  Google Scholar 

  7. Date H, Kusano KF, Matsubara H, et al. Living-donor lobar lung transplantation for pulmonary arterial hypertension after failure of epoprostenol therapy. J Am Coll Cardiol. 2007;50:523–7.

    Article  PubMed  Google Scholar 

  8. Date H, Aoe M, Nagahiro I, et al. Living-donor lobar lung transplantation for various lung diseases. J Thorac Cardiovasc Surg. 2003;126:476–81.

    Article  PubMed  Google Scholar 

  9. Date H, Aoe M, Sano Y, et al. Improved survival after living-donor lobar lung transplantation. J Thorac Cardiovasc Surg. 2004;128:933–40.

    Article  PubMed  Google Scholar 

  10. Date H, Sato M, Aoyama A, et al. Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patients. Eur J Cardiothorac Surg. 2015;47:967–72.

    Article  PubMed  Google Scholar 

  11. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122:164–72.

    Article  PubMed  Google Scholar 

  12. Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014 – an update from the pulmonary transplantation council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34:1–15.

    Article  PubMed  Google Scholar 

  13. Chen F, Kubo T, Yamada T, et al. Adaptation over a wide range of donor graft lung size discrepancies in living-donor lobar lung transplantation. Am J Transplant. 2013;13:1336–42.

    Article  CAS  PubMed  Google Scholar 

  14. Aoyama A, Chen F, Minakata K, et al. Sparing native upper lobes in living-donor lobar lung transplantation: Five cases from a single center. Am J Transplant. 2015;15:3202–7.

    Article  CAS  PubMed  Google Scholar 

  15. Toyooka S, Kusano KF, Goto K, et al. Right but left ventricular function recovers early after living-donor lobar lung transplantation in patients with pulmonary arterial hypertension. J Thorac Cardiovasc Surg. 2009;138:222–6.

    Article  PubMed  Google Scholar 

  16. Yusen RD, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart Lung Transplantation: Thirty-second official adult lung and heart-lung transplantation report – 2015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34:1264–77.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroshi Date M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Date, H. (2017). Lung Transplantation. In: Fukumoto, Y. (eds) Diagnosis and Treatment of Pulmonary Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-287-840-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-981-287-840-3_13

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-287-839-7

  • Online ISBN: 978-981-287-840-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics